Northpond Ventures, LP 13D and 13G filings for Telesis Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 4:50 pm Purchase | 2024-11-04 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures, LP | 1,039,577 45.900% | 5,031 (+0.49%) | Filing |
| 2024-07-18 5:42 pm Purchase | 2024-07-16 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures, LP | 1,034,546 47.700% | 1,672 (+0.16%) | Filing |
| 2024-06-10 8:40 pm Purchase | 2024-06-06 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures, LP | 1,032,874 47.600% | 15,826 (+1.56%) | Filing |
| 2023-06-07 5:00 pm Purchase | 2023-06-05 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures, LP | 1,017,048 47.900% | 470,152 (+85.97%) | Filing |
| 2023-04-18 9:45 pm Unchanged | 2023-04-17 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures, LP | 546,896 33.200% | 0 (Unchanged) | Filing |
| 2021-07-01 5:16 pm Purchase | 2021-06-22 | 13D | Telesis Bio, Inc. TBIO | Northpond Ventures, LP | 546,896 33.700% | 546,896 (New Position) | Filing |